{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:08:30Z","timestamp":1790777310284,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.humpath.2022.07.009","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T01:51:21Z","timestamp":1659318681000},"page":"152-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Updates in 2022 on the staging of testicular germ cell tumors"],"prefix":"10.1016","volume":"128","author":[{"given":"Sofia","family":"Canete Portillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Rais-Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1219-3797","authenticated-orcid":false,"given":"Cristina","family":"Magi-Galluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.07.009_bib1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2022.07.009_bib2","series-title":"WHO classification of Tumours of the urinary system and male genital organs","author":"Moch","year":"2016"},{"key":"10.1016\/j.humpath.2022.07.009_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.annonc.2022.01.002","article-title":"Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oldenburg","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2022.07.009_bib4","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.6004\/jnccn.2019.0058","article-title":"Testicular cancer, Version 2.2020, NCCN clinical practice guidelines in oncology","volume":"17","author":"Gilligan","year":"2019","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.humpath.2022.07.009_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MOU.0000000000000942","article-title":"Management of stage I testicular cancer","volume":"32","author":"Padayachee","year":"2022","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.humpath.2022.07.009_bib6","article-title":"Testicular cancer, Version 2.2022, NCCN clinical practice guidelines in oncology","author":"Gilligan","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.humpath.2022.07.009_bib7","series-title":"EAU guidelines on testicular cancer","author":"Laguna","year":"2022"},{"key":"10.1016\/j.humpath.2022.07.009_bib8","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/annonc\/mdy217","article-title":"ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up","volume":"29","author":"Honecker","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2022.07.009_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clgc.2016.05.005","article-title":"Value of supraregional multidisciplinary review for the contemporary management of testicular tumors","volume":"15","author":"Purshouse","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.humpath.2022.07.009_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAP.0b013e318159475d","article-title":"The most common, clinically significant misdiagnoses in testicular tumor pathology, and how to avoid them","volume":"15","author":"Ulbright","year":"2008","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2022.07.009_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2559.2005.02207.x","article-title":"The continued value of central histopathological review of testicular tumours","volume":"47","author":"Delaney","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.07.009_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/his.12657","article-title":"Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists","volume":"67","author":"Berney","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.07.009_bib13","series-title":"Urinary and male genital tumors","year":"2022"},{"key":"10.1016\/j.humpath.2022.07.009_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/his.14675","article-title":"An introduction to the WHO 5th edition 2022 Classification of testicular tumours","author":"Berney","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.07.009_bib15","series-title":"AJCC cancer staging manual","first-page":"735","article-title":"Testis","author":"Brimo","year":"2017"},{"key":"10.1016\/j.humpath.2022.07.009_bib16","series-title":"AJCC cancer staging manual","author":"Amin","year":"2018"},{"key":"10.1016\/j.humpath.2022.07.009_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/his.12958","article-title":"Germ cell neoplasia in situ (GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy","volume":"69","author":"Berney","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.07.009_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5858\/arpa.2019-0544-RA","article-title":"Updates in staging and reporting of genitourinary malignancies","volume":"144","author":"Cornejo","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2022.07.009_bib19","volume":"649","author":"Edge","year":"2011"},{"key":"10.1016\/j.humpath.2022.07.009_bib20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.01.003","article-title":"Changes of tumour-node-metastasis staging in 2017: concepts and evolutions in the European and American continents","volume":"73","author":"Comperat","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2022.07.009_bib21","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/PAS.0000000000000844","article-title":"Reporting and staging of testicular germ cell tumors: the international society of urological pathology (ISUP) testicular cancer consultation conference recommendations","volume":"41","author":"Verrill","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.07.009_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41379-021-00912-9","article-title":"Testicular germ-cell tumors with spermatic cord involvement: a retrospective international multi-institutional experience","volume":"35","author":"Rodriguez Pena","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.07.009_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/PAS.0000000000001008","article-title":"The significance of spermatic cord involvement by testicular germ cell tumors: should we be staging discontinuous invasion from involved lymphovascular spaces differently from direct extension?","volume":"42","author":"Sanfrancesco","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.07.009_bib24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.path.2018.07.005","article-title":"Updates in staging and reporting of testicular cancer","volume":"11","author":"Magers","year":"2018","journal-title":"Surgical pathology clinics"},{"key":"10.1016\/j.humpath.2022.07.009_bib25","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/PAS.0000000000000917","article-title":"Do nonseminomatous germ cell tumors of the testis with lymphovascular invasion of the spermatic cord merit staging as pT3?","volume":"41","author":"Gordetsky","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.07.009_bib26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.5858\/arpa.2016-0226-OA","article-title":"The significance of lymphovascular invasion of the spermatic cord in the absence of cord soft tissue invasion","volume":"141","author":"McCleskey","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2022.07.009_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/his.13736","article-title":"Datasets for the reporting of neoplasia of the testis: recommendations from the international collaboration on cancer reporting","volume":"74","author":"Berney","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.07.009_bib28","series-title":"Dataset for histopathological reporting of testicular neoplasms","author":"Berney","year":"2020"},{"key":"10.1016\/j.humpath.2022.07.009_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/his.13200","article-title":"UICC drops the ball in the 8th edition TNM staging of urological cancers","author":"Delahunt","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.07.009_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1148\/rg.311105072","article-title":"Pathways of lymphatic spread in male urogenital pelvic malignancies","volume":"31","author":"Pano","year":"2011","journal-title":"Radiographics"},{"key":"10.1016\/j.humpath.2022.07.009_bib31","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1016\/j.jacr.2022.02.009","article-title":"ACR appropriateness criteria R staging and surveillance of testicular cancer: 2021 update","volume":"19","author":"Expert Panel on Urological I","year":"2022","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.humpath.2022.07.009_bib32","first-page":"261","article-title":"Testicular cancer: diagnosis and treatment","volume":"97","author":"Baird","year":"2018","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.humpath.2022.07.009_bib33","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S1470-2045(03)01278-6","article-title":"Part I: testicular cancer--management of early disease","volume":"4","author":"Jones","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2022.07.009_bib34","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.21037\/tau.2019.09.32","article-title":"Contemporary management of early stage testicular seminoma","volume":"9","author":"Aydin","year":"2020","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.humpath.2022.07.009_bib35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ucl.2019.04.001","article-title":"Management of clinical stage I germ cell tumors","volume":"46","author":"Roth","year":"2019","journal-title":"Urol Clin"},{"key":"10.1016\/j.humpath.2022.07.009_bib36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/JU.0000000000000318","article-title":"Diagnosis and treatment of early stage testicular cancer: AUA guideline","volume":"202","author":"Stephenson","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2022.07.009_bib37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.clon.2016.02.008","article-title":"Stage II testicular seminoma: patterns of care and survival by treatment strategy","volume":"28","author":"Glaser","year":"2016","journal-title":"Clin Oncol"},{"key":"10.1016\/j.humpath.2022.07.009_bib38","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2013.53.5831","article-title":"Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort","volume":"32","author":"Daugaard","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2022.07.009_bib39","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/PAS.0000000000001352","article-title":"Interobserver agreement in vascular invasion scoring and the added value of immunohistochemistry for vascular markers to predict disease relapse in stage I testicular nonseminomas","volume":"43","author":"Lobo","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.07.009_bib40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.eururo.2019.11.022","article-title":"The 111 study: a single-arm, phase 3 trial evaluating one cycle of bleomycin, etoposide, and cisplatin as adjuvant chemotherapy in high-risk, stage 1 nonseminomatous or combined germ cell tumours of the testis","volume":"77","author":"Cullen","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2022.07.009_bib41","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.20.03292","article-title":"Survival and new prognosticators in metastatic seminoma: results from the IGCCCG-update consortium","volume":"39","author":"Beyer","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2022.07.009_bib42","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1200\/JCO.20.03296","article-title":"Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG update consortium","volume":"39","author":"Gillessen","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2022.07.009_bib43","doi-asserted-by":"crossref","first-page":"838 e1","DOI":"10.1016\/j.urolonc.2021.09.011","article-title":"Validation of testicular germ cell tumor staging in nationwide cancer registries","volume":"39","author":"Badia","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2022.07.009_bib44","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2022.07.009_bib45","doi-asserted-by":"crossref","first-page":"809 e19","DOI":"10.1016\/j.urolonc.2019.07.020","article-title":"The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: a registry of the International Global Germ Cell Tumor Collaborative Group (G3)","volume":"37","author":"Seidel","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2022.07.009_bib46","article-title":"Long non-coding RNA RFPL3S functions as a biomarker of prognostic and immunotherapeutic prediction in testicular germ cell tumor","volume":"13","author":"Guo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.humpath.2022.07.009_bib47","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/jcmm.14013","article-title":"Clinical utility of plasma miR-371a-3p in germ cell tumors","volume":"23","author":"Mego","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.humpath.2022.07.009_bib48","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.juro.2018.02.068","article-title":"Serum miRNA predicts viable disease after chemotherapy in patients with testicular nonseminoma germ cell tumor","volume":"200","author":"Leao","year":"2018","journal-title":"J Urol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:40:56Z","timestamp":1758645656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722001824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":48,"alternative-id":["S0046817722001824"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.07.009","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates in 2022 on the staging of testicular germ cell tumors","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}